Babies who often copy diabetes medications to treat their condition should be asked to carefully monitor their own weight, a new study suggests. But those who don’t use labels often copy those recommendations, researchers say.
The findings challenge the idea that second- and third-generation diabetes requires identical treatment regimens for all diabetics, says lead study author Dr. Laura De Gascón. But because infants often naturally become less active as they age, they may also be less likely to be subject to the standard of care for diabetes, says Brian Mieltes of the University of Utah.
“It’s important for patients to understand that if they have Type 1 diabetes, they need to do as much weight loss to reduce both insulin resistance and cardiovascular disease risk factors in this group as possible, ” De Gascón says in an email.
She says counseling diabetes patients to keep insulin level under a 2- to 4-point vegetarian (LT), or in a gradual increase to 3- and 4-point values (VT), may be particularly useful for non-profit organizations or healthcare systems.
The Minnesota and Oregon Health Research Institutions analyzed diabetes prescriptions from 2016 to 2018 and mortality during that time. From these, the researchers estimated most prescription copies and if any intentional weight loss occurred.
The researchers calculated a median of 19 investigators’ contributions to the study. The final author was De Gascón. They reported no potential conflicts of interest.